Skip to content
天士力生物
|中文|English
  • Homepage
  • About Us
    • Company Profile
    • Chairman’s Message
    • Mission and Vision
    • Board of Directors
    • Management Team
    • Contact Us
  • Product Center
    • Marketed Products
    • Pipeline
    • Clinical Recruitment
    • About PUK
  • R&D and Innovation
    • R&D Approach
    • R&D Platform
    • R&D  Team
    • Cooperation
  • Commercialization Capabilities
    • Manufacturing Process
    • Quality Management
    • Precision Marketing
  • News Center
  • Careers
    • Corporate Culture
    • Job Opportunities
  • Homepage
  • About Us
    • Company Profile
    • Chairman’s Message
    • Mission and Vision
    • Board of Directors
    • Management Team
    • Contact Us
  • Product Center
    • Marketed Products
    • Pipeline
    • Clinical Recruitment
    • About PUK
  • R&D and Innovation
    • R&D Approach
    • R&D Platform
    • R&D  Team
    • Cooperation
  • Commercialization Capabilities
    • Manufacturing Process
    • Quality Management
    • Precision Marketing
  • News Center
  • Careers
    • Corporate Culture
    • Job Opportunities

A leading innovative

biopharmaceutical company in China

  • Media Reports
  • Company News
Menu
  • Media Reports
  • Company News

Another Triumph in Tasly Biopharma Innovative Drug R&D — PCSK9 Monoclonal Antibody Approved for Clinical Trials

Read More »

Epidemic Prevention and Stable Production | Recording the 432 Hours of Sticking to the Post at the Production Workshop

Read More »

China's First Chronic Hepatitis B Drug T101 Approved to Enter Clinical Trials Successfully Completes the first subject Administration of Phase II

Read More »

Phase II Clinical Trial of Tasly Biopharma PUK (Recombinant Human Pro-urokinase for Injection) Thrombolysis for the Treatment of Acute Pulmonary Embolism Successfully Completes the Enrollment

Read More »

Tasly Biopharma’s Advanced Malignant Solid Tumors of Digestive Tract Drug T601 Successfully Completes the First Subject Administration of Phase I/IIa Clinical Trial

Read More »
Copyright © 2021 All Rights Reserved 天士力生物医药股份有限公司


沪ICP备 2021005430号-2


互联网药品信息服务资格证书编号(沪)-非经营性-2021-0008
Search for: